The programme will build UK capacity in AI, data science and biosciences, helping to address national skills gaps and drive innovation across health, agriculture and biotechnology. The project is part of Oxford’s contribution to a flagship doctoral training programme awarded by UK Research and Innovation (UKRI).
On his involvement in the ENAIBLE initiative, Mark said “AI driven approaches have the potential to transform biological research, from virtual cells to virtual immune systems, AI/ML has the capacity to provide new insights into the human immune system and accelerate development of new therapies for inflammatory disease. In ENAIBLE we will train the next generation of scientist equipped to lead the frontier of AI in the biosciences.”
Alongside Professor Coles, the Oxford researchers leading the programme are Michael Bronstein, DeepMind Professor of Artificial Intelligence, Blanca Rodriguez, Professor of Computational Medicine at the Department of Computer Science, and Ruth Baker, Professor of Applied Mathematics.
Read the full story on the Department of Computer Science website.